|
|
|
|
| LEADER |
01626nam a2200301 u 4500 |
| 001 |
EB001839996 |
| 003 |
EBX01000000000000001003985 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 100 |
1 |
|
|a Tran, Khai
|
| 245 |
0 |
0 |
|a Drugs for pulmonary arterial hypertension
|h Elektronische Ressource
|b comparative efficacy, safety, and cost-effectiveness
|c Khai Tran, Kathryn Coyle, Mohammed F. Jabr, Doug Coyle, Michel Boucher, Lisa Mielniczuk, John R. Swiston, Danielle Rabb, Karen Cimon, Julie Blouin, Michael Innes
|
| 260 |
|
|
|a Ottawa, Ontario
|b Canadian Agency for Drugs and Technologies in Health
|c March 2015, 2015
|
| 300 |
|
|
|a 1 PDF file (xx, 313 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliograpical references
|
| 653 |
|
|
|a Comparative Effectiveness Research
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Hypertension, Pulmonary / drug therapy
|
| 653 |
|
|
|a Antihypertensive Agents / therapeutic use
|
| 653 |
|
|
|a Antihypertensive Agents / economics
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH therapeutic review report
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK355844
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a The objective of this therapeutic review is to conduct a systematic review to assess the comparative efficacy and safety and to determine the cost-effectiveness of drug therapies for the treatment of pulmonary arterial hypertension (PAH) in adults
|